Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prosthetic arterial grafts.
Thirty-four platelet imaging studies were performed in 23 patients to determine whether platelet deposition could be detected in patients with vascular aneurysms (18 patients) or in patients in whom Dacron prosthetic grafts had been place (5 patients). In patients in whom abnormal platelet deposition was detected, the effect of administration of platelet-active drugs on platelet deposition was examined. Of the 18 patients with an aneurysm, 12 had positive studies on initial imaging and 2 had equivocally positive images. Of five patients with Dacron arterial grafts in place, four had diffuse platelet deposition in the grafts; the fifth patient had platelet deposition only in a pseudoaneurysm. Eight patients with an abdominal aneurysm and positive or equivocally positive baseline images were restudied during platelet-active drug therapy either with aspirin plus dipyridamole (seven patients) or with sulfinpyrazone (four patients). No patient studied during treatment with aspirin plus dipyridamole had detectably decreased platelet deposition compared with baseline determinations. In contrast, two of four patients studied while receiving sulfinpyrazone showed decreased platelet deposition. Thus, platelet imaging may be of value for studying platelet physiology in vivo and for assessing platelet-active drugs and the thrombogenicity of prosthetic graft materials in human beings.
D000005:Abdomen / Q000098:blood supply*; D000368:Aged; D000783:Aneurysm / Q000000981:diagnostic imaging*; D001014:Aortic Aneurysm / Q000000981:diagnostic imaging; D001158:Arteries / Q000000981:diagnostic imaging; D001241:Aspirin / Q000627:therapeutic use; D001705:Bioprosthesis; D001777:Blood Coagulation; D001792:Blood Platelets / Q000000981:diagnostic imaging*; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D007204:Indium; D008297:Male; D008875:Middle Aged; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013442:Sulfinpyrazone / Q000627:therapeutic use
D011868:Radioisotopes; D007204:Indium; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone